Ionis Pharmaceuticals Ownership | Who Owns Ionis Pharmaceuticals?
Ionis Pharmaceuticals Ownership Summary
Ionis Pharmaceuticals is owned by 104.99% institutional investors, 0.77% insiders. Fmr is the largest institutional shareholder, holding 15.04% of IONS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.34% of its assets in Ionis Pharmaceuticals shares.
IONS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ionis Pharmaceuticals | 104.99% | 0.77% | -5.75% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 21.89M | 15.04% | $1.04B |
| Vanguard group | 13.85M | 9.51% | $659.89M |
| T. rowe price investment management | 12.64M | 8.68% | $602.41M |
| Blackrock | 10.32M | 7.09% | $491.90M |
| Bellevue group | 8.26M | 5.68% | $393.69M |
| Wellington management group llp | 6.57M | 4.51% | $313.07M |
| State street | 4.19M | 2.88% | $199.72M |
| Price t rowe associates inc /md/ | 3.93M | 2.70% | $187.51M |
| Tweedy, browne | 3.45M | 2.37% | $164.65M |
| Bvf inc/il | 3.19M | 2.19% | $151.86M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tweedy, browne | 3.45M | 7.57% | $164.65M |
| Bellevue group | 8.26M | 6.40% | $393.69M |
| Bvf inc/il | 3.19M | 4.26% | $151.86M |
| Orion investment | 218.57K | 4.15% | $10.42M |
| Sicart associates | 191.52K | 3.50% | $9.13M |
| Sector gamma as | 170.00K | 3.03% | $8.10M |
| Great point partners | 330.00K | 3.01% | $15.73M |
| Privium fund management b.v. | 247.27K | 2.85% | $11.16M |
| Deep track capital, lp | 2.00M | 2.85% | $95.32M |
| Cutter capital management, lp | 160.17K | 2.30% | $7.63M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | 2.25M | 0.02% | 1.41M |
| Artisan partners limited partnership | 1.67M | 0.12% | 1.25M |
| Norges bank | 1.02M | 0.01% | 1.02M |
| Wellington management group llp | 6.57M | 0.06% | 873.11K |
| Bvf inc/il | 3.19M | 4.26% | 757.76K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Clearbridge investments | 2.16M | 0.08% | -2.31M |
| Pictet asset management sa | 2.41M | 0.13% | -1.33M |
| Macquarie group | 1.87M | 0.10% | -1.33M |
| Balyasny asset management | - | - | -1.08M |
| T. rowe price investment management | 12.64M | 0.38% | -677.43K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.02M | 0.01% | 1.02M | $48.58M |
| Great point partners | 330.00K | 3.01% | 330.00K | $15.73M |
| Logos global management lp | 300.00K | 1.15% | 300.00K | $14.30M |
| Integral health asset management | 250.00K | 1.13% | 250.00K | $11.91M |
| Orion investment | 218.57K | 4.15% | 218.57K | $10.42M |
Sold Out
| Holder | Change |
|---|---|
| Assetmark | -1.00 |
| Bokf, na | -7.00 |
| Concourse financial group securities | -26.00 |
| Corecap advisors | -26.00 |
| First pacific financial | -29.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 378 | 0.27% | 156,005,896 | 8.92% | 104 | 1.08% | 182 | 3.41% | 106 | -17.83% |
| Jun 30, 2024 | 375 | -2.60% | 143,227,487 | 1.66% | 98 | 1.02% | 176 | 2.92% | 127 | 0.79% |
| Mar 31, 2024 | 385 | 1.05% | 140,888,836 | -0.88% | 98 | 1.00% | 171 | -9.04% | 126 | 5.88% |
| Dec 31, 2023 | 381 | 17.59% | 142,138,886 | 2.61% | 99 | 1.06% | 188 | 38.24% | 119 | 10.19% |
| Sep 30, 2023 | 324 | 3.18% | 138,518,212 | 2.21% | 96 | 1.08% | 136 | 3.03% | 108 | -1.82% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 10.00M | 6.34% | 287.29K |
| Fidelity Growth Compy Commingled Pl O | 9.71M | 6.16% | 90.97K |
| BB Biotech AG Ord | 7.85M | 4.98% | -360.00K |
| Fidelity Growth Company Fund | 7.30M | 4.63% | 253.01K |
| Vanguard Health Care Inv | 5.73M | 3.64% | 1.54M |
| T. Rowe Price Mid-Cap Growth | 5.30M | 3.36% | 606.80K |
| T. Rowe Price US Mid-Cap Growth Equity | 5.30M | 3.36% | 603.80K |
| Vanguard Total Stock Mkt Idx Inv | 4.48M | 2.84% | -23.41K |
| Vanguard Small Cap Index | 3.56M | 2.25% | 6.95K |
| Tweedy, Browne International Value Fund | 2.59M | 1.64% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 12, 2024 | Swayze Eric | EVP Research | Sell | $45.28K |
| Nov 12, 2024 | Monia Brett P | Chief Executive Officer | Sell | $252.29K |
| Nov 12, 2024 | LOSCALZO JOSEPH | - | Sell | $511.43K |
| Oct 16, 2024 | Swayze Eric | EVP Research | Sell | $2.03K |
| Feb 02, 2024 | Geary Richard S | EVP, Chief Development Officer | Sell | $99.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 4 |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 9 |
| 2024 Q1 | - | 33 |
| 2023 Q4 | - | 21 |
IONS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools